CTRI/2021/01/030526
Not yet recruiting
未知
A prospective study to evaluate the role of Telehealth in patients with spinal cord injury
Department of Orthopaedics PT BD Sharma PGIMS Rohtak0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: Z718- Other specified counseling
- Sponsor
- Department of Orthopaedics PT BD Sharma PGIMS Rohtak
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with traumatic Spinal cord injury giving consent for participation in the study
Exclusion Criteria
- •1\.Patients with non traumatic spinal cord injury
- •2\.patients with head injury, medically unstable condition,have cognitive or verbal impairment,have clinically significant medical condition that would compromise participation in the trial
- •3\.patients who dont have access to a phone
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Telehealth Programme for the Treatment of Toileting Problems in Children on the Autism SpectrumAutism Spectrum DisorderToilet training difficultiesMental Health - Autistic spectrum disordersNeurological - Other neurological disordersACTRN12621001447842A/Prof. Laurie McLay30
Not yet recruiting
Not Applicable
A Telehealth Programme for the Treatment of Eating/Feeding Problems in Children on the Autism SpectrumACTRN12621001424897Associate Professor Laurie McLay30
Recruiting
Phase 2
A study looking at the effect positron emission tomography (PET) scans have on the treatment decisions specialists make in patients with suspected cancer of the pancreas.ACTRN12607000604404Royal Brisbane Hospital90
Recruiting
Not Applicable
The impact of heterogeneities of RAS/BRAF in tissue and ctDNA on the efficacy of anti EGFR antibody in advanced colorectal cancercolorectal cancerRAS BRAFwild coloretal cancerD015179JPRN-jRCT1050230049Kozo Kataoka240
Recruiting
Not Applicable
An observational study to evaluate the impact of the gene panel test FoundationOne CDx or FoundationOne Liquid CDx on treatment decision-making in metastatic and recurrent breast cancer throughout Japan as a whole.Patients with stage IV or recurrent breast cancer who have distant metastases at registrationJPRN-UMIN000038065Japan Breast Cancer Research Group600